Overview

Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes Patients

Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study is being carried out to see if dapagliflozin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glipizide (sulphonylurea) as an addition to metformin treatment.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Bristol-Myers Squibb
Treatments:
Dapagliflozin
Glipizide
Metformin